Invion Ltd. | Key People and Executives
Mitchell Glass
Executive Director & Chief Medical Officer
James A. Campbell
Independent Non-Executive Director
Gregory Collier
Chief Executive Officer & Managing Director
Craig Newton
Chief Operating Officer
Mitchell Glass
Executive Director & Chief Medical Officer
Seth Yakatan
Vice President-Business Development
James A. Campbell
Independent Non-Executive Director
| Address |
722 High Street
Melbourne Victoria (VIC) 3102
Australia
|
|
Employees
|
- |
| Website |
http://www.inviongroup.com |
| Updated |
07/08/2019 |
| Invion Ltd. engages in the development of treatments for respiratory and autoimmune disease. It develops the following drug assets: nadolol, zafirlukast, and ala-Cpn10. The company was founded on October 11, 2000 and is headquartered in Chermside, Australia. |
